|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Verenium and Novus Collaborate to Develop New Enzymes for Animal Markets
|
Bruce V. Bigelow |
06/27/11 |
San Diego
|
|
Verenium, Shorn of Biofuels Business, Returns to San Diego and its Diversa Roots
|
Bruce V. Bigelow |
03/22/11 |
San Diego
|
|
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug
|
Ryan McBride |
01/19/11 |
Boston
|
|
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs
|
Gregory T. Huang |
08/24/10 |
Boston
|
|
Biofuels Reboot: Verenium Sells Cellulosic Biofuels Business to BP for $98M, Includes San Diego R&D Facilities
|
Erin Kutz |
07/15/10 |
Boston
|
|
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/04/10 |
Boston
|
|
Thermo Buys Fermentas for $260M
|
Ryan McBride |
05/27/10 |
Boston
|
|
Quanterix Uses Fiber Optics to Find Cancer Protein, Nears New Funding Round
|
Ryan McBride |
05/27/10 |
Boston
|
|
Bio Architecture Lab Raises Cash, OVP Invests in Limerick, & More Seattle-Area Life Sciences News
|
Eric Hal Schwartz |
07/16/09 |
Seattle
|
|
Bio Architecture Lab, a UW Spinout, Raises $3.4M for Renewable Chemicals and Biofuels
|
Gregory T. Huang |
07/15/09 |
Seattle
|
|
Data Domain Founder Talks EMC Deal, Arzeda Teams Up With Dupont, EndoGastric Takes In $7.5M, & More Seattle-Area Deals News
|
Gregory T. Huang |
07/14/09 |
Seattle
|
|
Arzeda Teaming with DuPont
|
Eric Hal Schwartz |
07/13/09 |
Seattle
|
|
Arzeda, a University of Washington Spinout, Sees Future in Directed Evolution
|
Luke Timmerman |
09/12/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.